immune modulation in PD : Scientists achi... - Cure Parkinson's

Cure Parkinson's

26,504 members27,915 posts

immune modulation in PD : Scientists achieve research milestone

aspergerian profile image
3 Replies

Scientists achieve research milestone with Parkinson's disease

Date: March 27, 2017

Source: University of Nebraska Medical Center (UNMC)

Summary: In a Phase I clinical study, researchers were able to transform

the immune system by taking cells damaged in Parkinson’s disease and

making them cells that protect and defend against brain injury.

sciencedaily.com/releases/2...

* * * *

open access

Evaluation of the safety and immunomodulatory effects of sargramostim in

a randomized, double-blind phase 1 clinical Parkinson’s disease trial

nature.com/articles/s41531-...

Written by
aspergerian profile image
aspergerian
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Marcomando profile image
Marcomando

Sounds promising - like so many of these trials...

Still waiting

Catlou profile image
Catlou

So this is a repurposed drug originally used to increase t-cells. In that case off it works can't they apply for that special status to move things along?

aspergerian profile image
aspergerian in reply toCatlou

Perhaps Dr. Gendelman (lead author) would appreciate a note of appreciation and encouragement.

Howard E. Gendelman

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA

Contact Howard E. Gendelman

nature.com/articles/s41531-...

Not what you're looking for?

You may also like...

Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD

Highlights • Oral NR increases brain NAD levels in individuals with Parkinson’s disease • NR...

Stem Cells Trials

I want to make a list here. Please reply with links...

Fasudil-treated, intranasally-delivered, bone-marrow-derived stem cells ... in a mouse model of PD

It sounds like a breakthrough. But how long before a Phase 1 clinical trial? PNT article -...
jeffreyn profile image

ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)

https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?releaseID=111474&d=20